loader
Page is loading...
Print Logo Logo
Amy Kluesner
OVERVIEW

Amy Kluesner

Of Counsel

Atlanta

3340 Peachtree Rd NE
Suite 2900
Atlanta, GA 30326-1092

P 470-832-7589

F 404-264-4033

A strategic-minded deal lawyer, Amy Kluesner is driven to find solutions for her clients to achieve their long-term goals. Amy is valued for her conscientious responsiveness and resolute focus on client needs. She effectively negotiates transactions while focusing on business objectives and ensuring compliance with relevant laws.

OVERVIEW

A strategic-minded deal lawyer, Amy Kluesner is driven to find solutions for her clients to achieve their long-term goals. Amy is valued for her conscientious responsiveness and resolute focus on client needs. She effectively negotiates transactions while focusing on business objectives and ensuring compliance with relevant laws.

Principled and approachable, Amy is a trusted advisor who cares deeply about the clients she serves. She offers comprehensive advice to healthcare providers and private equity funds, providing counsel to public and private entities on, mergers and acquisitions, divestitures, joint ventures, corporate governance matters and associated healthcare regulatory requirements. She identifies and mitigates risk, navigates organizations through growth and change and collaborates closely with business leaders to resolve complex legal issues. Amy’s industry know-how, coupled with her joyful personality, enable her to effectively and efficiently close deals. 

Before joining Barnes & Thornburg, Amy served as general counsel for a dental support organization (DSO) and for a private equity-backed healthcare company. She is adept at providing outside general counsel services to growing portfolio companies, particularly with regard to mergers and acquisitions and regulatory compliance in the DSO space. 

Amy also spent several years in private practice as a transactional attorney, representing domestic and global companies as both acquirers and sellers in asset and stock M&A deals. She is skilled in coordinating all aspects of a transaction and efficiently moving transactions from the initial letter of intent stage to closing.

Professional and Community Involvement

Adjunct professor, Marian University, business law, ethics and moral issues

Boy Scouts of America, Atlanta Area Council, Den Leader

Board member, Young Catholic Professionals

Member, Dominican Sisters of St. Cecilia Planned Giving Advisory Committee

Honors

State Bar of Georgia Pro Bono All Stars, 2017, 2018

Indianapolis Bar Association Pro Bono Hall of Fame, 2015

American Bar Association, Business Law Fellow (2013-2015)

EXPERIENCE
EXPERIENCE
  • Represented a dental support organization (DSO) in multiple stock and asset acquisitions in various states throughout the Southeast, as well as ongoing advisory with regard to real estate leases, vendor services contracts, licensure, and regulatory matters
  • Represented a physical therapy portfolio company in multiple stock and asset acquisitions in various states, as well as ongoing general corporate advisory with regard to real estate leases, commercial contracts, and under arrangements with hospitals and health systems 
  • Represented a hospice and home health service provider backed by private equity in its acquisition of a NYSE-listed home health and hospice business for approximately $80 million
  • Represented a privately held pharmaceutical company in its acquisition of a publicly traded pharmaceutical company in a tender offer and subsequent merger for approximately $475 million
  • Represented a multi-state specialty pharmacy in its acquisition of all of the equity interests of another specialty pharmacy, as well as ongoing general corporate matters
  • Represented a global medical product and device company in the sale of a subsidiary
  • Represented a nonprofit hospital, owned by a hospital authority, in its purchase of a regional medical center out of bankruptcy for approximately $70 million
  • Represented one of the nation’s largest publicly-traded home health companies in a system-wide joint venture with another health system valued at over $200 million
  • Represented a nonprofit health system in its negotiation of an affiliation with one of the nation’s leading providers of health care services in a transaction valued at approximately $500 million
  • Represented a NYSE-listed medical technology company in the sale of its surgical and infection prevention business to another publicly-traded company for approximately $700 million
  • Represented a diversified healthcare services corporation in its disposition of two hospitals 
  • Represented a large developer of transitional health care properties in various private equity deals
  • Represented a private equity firm in various transactions, including the following closed matters:
      • Disposition of home health and hospice portfolio company to a private equity firm
      • Acquisition of a manufacturer of synthetic building products  
  • Represented a portfolio company that is an operator of behavioral health care treatment centers and programs in various acquisitions of other behavioral health companies
  • Represented a NYSE-listed consumer healthcare company in its SEC reporting and disclosure, and corporate governance matters
  • Represented a NYSE-listed medical technology company in its SEC reporting and disclosure, and corporate governance matters
  • Represented a biotech company in its Series A financing and general corporate matters
  • Represented a major clinical staffing company in various corporate, securities, and M&A matters   
  • Represented a nonprofit entity in its establishment of a needs-based pharmacy (pro bono) 
Presentations
  • ABA Business Law Section Spring Meeting, Program Chair and Moderator for CLE titled, “Making it Rain: Business Development for Young Lawyers,” San Francisco, California (April 2015)
  • ABA Business Law Section Fall Meeting, Panelist for CLE titled, “Enterprise Risk Management for Nonprofit Organizations: Meeting Challenges to Tax Exempt Status,” Chicago, Illinois (September 2014)
Publications

Harvard Journal of Sports and Entertainment Law, “And They're Off: Eliminating Drug Use in Thoroughbred Racing,” July 1, 2012

INSIGHTS & EVENTS
Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.